Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Molecular Partners AG

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Molecular Partners is a Swiss clinical-stage biotech company developing DARPin-based protein therapeutics. DARPins are engineered binding proteins designed to target diseases including oncology, ophthalmology, and infectious diseases.